Semorex acquired by MYOS corporation
Latest Deals
Grant Avenue Capital Recapitalizes CREO
QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally
Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering
Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America
Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives
PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing
ZebraSci Acquired by BD to Enhance Combination Product Testing Capabilities
Pyxant Labs Receives Majority Investment from ArchiMed
Pyxant Labs Bolsters Capabilities in Acquisition of Covance by Labcorp’s SLC Bioanalytical Site
Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners
Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses
HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners
MolecularMD has been acquired by ICON Plc.
Santus Laboratories (owned by HealthEdge Partners) sold Cough/Cold asset to Reliable1 – October 2018
Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza
PhenoPath has been acquired by Quest Diagnostics September 2018
Santus Laboratories (owned by HealthEdge Partners) was purchased by DermaRite (owned by Tailwind Capital Group) August 2018
OmniSeq Received a Strategic Investment from HITACHI April 12, 2018
MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018
